Tekla Capital Management’s Cellectis CLLS Stock Holding History
Bought
Maintained
Sold
Other funds holding CLLS
AIM
CS
CII
NAMA
B
Tekla Capital Management's CLLS Position: Q2 2021 in Review
Tekla Capital Management sold out of Cellectis (CLLS) in Q2 2021, closing a stake of 11,955 shares — an estimated $242K sold.
Tekla Capital Management first reported a position in CLLS in Q1 2015 and held it in 25 quarters. The position peaked at $9.04M in Q4 2017. 78 funds tracked by Wall St. Rank hold CLLS as of Q2 2021.
- Tekla Capital Management reported no remaining Cellectis position as of Q2 2021 after selling out during the quarter.
- Tekla Capital Management sold 11,955 Cellectis shares in Q2 2021, an estimated $242K.
- Tekla Capital Management first reported a position in Cellectis in Q1 2015 and held it in 25 quarters.
- Tekla Capital Management's Cellectis position peaked at $9.04M in Q4 2017.
- 78 funds tracked by Wall St. Rank held Cellectis as of Q2 2021.
Based on Tekla Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.